UGHealthcare Stock Forum

$Riverstone(AP4.SG)$$Top Glove(BVA.SG)$
Riverstone may have bottomed at 0.78 and is rising again. Top Glove is also rising.
$Medtecs Intl(546.SG)$$UGHealthcare(8K7.SG)$

$Riverstone(AP4.SG)$$Top Glove(BVA.SG)$
Riverstone's support is around 0.76-0.765 as I said on Apr 1. Support for Top Glove is around 0.22-0.225.
$Medtecs Intl(546.SG)$$UGHealthcare(8K7.SG)$

$Riverstone(AP4.SG)$
Glove sales to pick up in 2nd half of year, profitability to improve - RHB IB. Keeping its overweight call on the sector, it said that with the industry's excess capacity gradually phasing out, the sector should achieve demand- supply equilibrium by by the end of 2024.
Glove sales to pick up in 2nd half of year, profitability to improve - RHB IB
$Top Glove(BVA.SG)$$Medtecs Intl(546.SG)$$UGHealthcare(8K7.SG)$

$Riverstone(AP4.SG)$
Phillip Capital said the worst is over for Malaysian rubber glove sector. Phillip Capital has initiated coverage on the Malaysian rubber glove sector with an "overweight" rating and said the supply-demand dynamics for the glove market are expected to further recover in 2024.
In a sector update on Tue, the research house said demand is expected to pick up on re-stocking activities following past two years of inventory adjustments.
It said average selling price (ASP) has stabi...

$Top Glove(BVA.SG)$
Hong Leong Investment Bank Bhd (HLIB) views Top Glove Corp Bhd's share price decline as an opportunity for investors to accumulate on weakness, in anticipation of a turnaround expected in financial year 2025 forecast.
HLIB said Top Glove's share price had retracted more than 10% over the past two months.
Meanwhile, it noted that Top Glove's sales volume has continued to show encouraging growt...

$Top Glove(BVA.SG)$
Glove demand is on the rise, says the world's largest glove maker, as it announced encouraging sales growth in the three months period ended Feb 29, 2024.
During the quarter, Top Glove Corp Bhd said its sales volume jumped 18% over the preceding quarter as customers replenished their inventories while it also benefited from trade diversions as Chinese manufacturers were placed on import alert by the US Food and Drug Administration.
In a briefing follow...

$Riverstone(AP4.SG)$
RHB have upgraded Riverstone to Buy from Neutral, with new DCF-derived 0.93 TP from 0.74, 27% upside and c.3% yield.
They believe it is in a sweet spot to capitalise on the recovery of global semiconductor sales. On healthcare gloves, management intends to focus on high specialty products following the completion of revamping its generic production line to a customised production line. They like the company for its unique exposure to the cleanroom segment, above-industry mar...

$UGHealthcare(8K7.SG)$ Healthcare let's gooo..

$Riverstone(AP4.SG)$
CGS CIMB are overweight on the gloves sector - 4Q23 marks a fundamental inflection point. They believe the glove industry is showing early signs of recovery.
They think RSTON can emerge stronger from the industry downcycle vs. peers with its nimble execution, as it prioritises higher-margin customised products and its unique cleanroom offerings. They have an Add call and tp of 0.88 for RSTON, pegged to 16.0x CY25F P/E.
Riverstone's 4Q23 net profit of RM68m (+14% qoq, +61% yo...

$UGHealthcare(8K7.SG)$
UGH posted better gross profit and better gross margin in 1H2024.
UGH posted better gross profit and better gross margin in 1H2024
$Top Glove(BVA.SG)$$Riverstone(AP4.SG)$$Medtecs Intl(546.SG)$